| scholarly article | Q13442814 |
| P50 | author | Mehmet Ali Deveci | Q56811248 |
| P2093 | author name string | Mustafa Tekin | |
| Semra Paydaş | |||
| Cenk Özkan | |||
| Ömer Sunkar Biçer | |||
| Gülfiliz Gönlüşen | |||
| P2860 | cites work | RANK is essential for osteoclast and lymph node development | Q24598872 |
| A High-grade Sarcoma Arising in a Patient With Recurrent Benign Giant Cell Tumor of the Proximal Tibia While Receiving Treatment With Denosumab | Q27000565 | ||
| The clinical approach toward giant cell tumor of bone | Q27024555 | ||
| Denosumab for prevention of fractures in postmenopausal women with osteoporosis | Q28254528 | ||
| Giant cell tumor of bone: treatment and outcome of 214 cases | Q28271725 | ||
| Giant cell tumor of bone | Q28296018 | ||
| Denosumab in postmenopausal women with low bone mineral density | Q28298728 | ||
| Bisphosphonate treatment of aggressive primary, recurrent and metastatic Giant Cell Tumour of Bone. | Q30988491 | ||
| Local control of giant cell tumors of the long bone after aggressive curettage with and without bone cement | Q34334579 | ||
| Molecular profiling of giant cell tumor of bone and the osteoclastic localization of ligand for receptor activator of nuclear factor kappaB | Q35084886 | ||
| Histologically verified lung metastases in benign giant cell tumours--14 cases from a single institution. | Q35212194 | ||
| Giant cell tumour of bone: new treatments in development | Q35662668 | ||
| Surgical downstaging in an open-label phase II trial of denosumab in patients with giant cell tumor of bone | Q35935409 | ||
| RANKL, denosumab, and giant cell tumor of bone. | Q38009727 | ||
| Giant cell tumor of bone: a basic science perspective | Q38051946 | ||
| Giant cell tumor of bone: current treatment options | Q38208716 | ||
| Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study | Q38448131 | ||
| Comparison of the anti-tumor effects of denosumab and zoledronic acid on the neoplastic stromal cells of giant cell tumor of bone | Q39092826 | ||
| Serial arterial embolization for large sacral giant-cell tumors: mid- to long-term results | Q39335991 | ||
| Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study. | Q42648818 | ||
| Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study | Q42829926 | ||
| Does curettage without adjuvant therapy provide low recurrence rates in giant-cell tumors of bone? | Q47270970 | ||
| Denosumab-treated Giant Cell Tumor of Bone Exhibits Morphologic Overlap With Malignant Giant Cell Tumor of Bone. | Q50978538 | ||
| A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system. | Q52228023 | ||
| Malignancy in giant cell tumor of bone | Q57003905 | ||
| Metaphyseal and diaphyseal localization of giant cell tumors | Q66896489 | ||
| RANK Expression as a cell surface marker of human osteoclast precursors in peripheral blood, bone marrow, and giant cell tumors of bone | Q80182596 | ||
| Gene expression in giant-cell tumors | Q80931223 | ||
| Giant cell tumor of bone | Q81537279 | ||
| Pre-operative selective arterial embolization as a neoadjuvant therapy for proximal humerus giant cell tumor of bone: radiological and histological evaluation | Q84358055 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1-6 | |
| P577 | publication date | 2016-10-24 | |
| P1433 | published in | Acta Orthopaedica et Traumatologica Turcica | Q4676738 |
| P1476 | title | Clinical and pathological results of denosumab treatment for giant cell tumors of bone: Prospective study of 14 cases | |
| P478 | volume | 51 |
| Q93113374 | A new computerized tomography classification to evaluate response to Denosumab in giant cell tumors in the extremities |
| Q92196136 | Challenges of denosumab in giant cell tumor of bone, and other giant cell-rich tumors of bone |
| Q99638392 | Denosumab for Effective Tumor Size Reduction in Patients With Giant Cell Tumors of the Bone: A Systematic Review and Meta-Analysis |
| Q93048081 | Evaluation of Local Recurrence in Giant-Cell Tumor of Bone Treated by Neoadjuvant Denosumab |
| Q90618906 | Giant cell tumor of bone: Unusual features of a rare tumor |
| Q92344109 | Malignant Sarcomatous Transformation of Benign Giant Cell Tumor of Bone after Treatment with Denosumab Therapy: A Literature Review of Reported Cases |
| Q90741192 | Preoperative Cytoreduction of Clival Giant Cell Tumor: An Effective Replication of the Systemic Modality in the Skull Base |
| Q41612401 | TRAIL-R1 as a novel surface marker for circulating giant cell tumor of bone |
| Q41387696 | Total en bloc spondylectomy of the eleventh thoracic vertebra following denosumab therapy for the treatment of a giant cell tumor |
Search more.